Esbriet
Idiopathic Pulmonary Fibrosis
200 · 400mg
utilized to manage idiopathic pulmonary fibrosis to alleviate lung fibrosis progression.
Pirfenidone is the medicine ingredient covered on this page. The catalog summary describes it as follows: Reduces collagen synthesis to slow the progression of scarring in idiopathic pulmonary fibrosis management. The products below may vary by brand, strength, form, release profile, or combination ingredients, so use the listing as a checkpoint before comparing it with a prescription or product label.
Idiopathic Pulmonary Fibrosis
200 · 400mg
utilized to manage idiopathic pulmonary fibrosis to alleviate lung fibrosis progression.
Respiratory medicines are often judged by symptom control and device technique, not only by the active ingredient.
For Pirfenidone, the starting fact is its catalog description: Reduces collagen synthesis to slow the progression of scarring in idiopathic pulmonary fibrosis management. That sentence tells you what to verify next - the diagnosis, the product form, and the instructions that come with the exact listing.
Severe breathlessness, blue lips, inability to speak full sentences, chest pain, low oxygen readings, or rapid worsening needs urgent help.
Frequent reliever use or night waking suggests the respiratory plan should be reviewed.
Tell a healthcare professional about current medicines, supplements, allergies, pregnancy or breastfeeding, kidney or liver disease, and any previous reaction to this ingredient or its drug class.
This page provides an educational overview of Pirfenidone and does not replace medical advice, diagnosis, product labelling, or prescribing instructions. Individual products can differ in active ingredient combinations, strength, formulation, storage, route, and monitoring requirements. Do not start, stop, switch, or combine medicines based only on this catalog page; use the specific product label and guidance from a qualified healthcare professional.